iEmoji Feeds @Journal of Clinical Oncology (JCO_ASCO)

1.

JCO_ASCO
Functional engagement of the PD-1/PD-L1 complex but not PD-L1 expression is highly predictive of a person's respo… twitter.com/i/web/status/1…
15 Mar 23 copy & paste +upvote -downvote 🆕 Functional engagement of the PD-1/PD-L1 complex but not PD-L1 expression is highly predictive of a person's respo… https://t.co/TRB5TCcmIS

2.

JCO_ASCO
Data from this one-stop-shop comprehensive #CancerScreening center shows early detection of many different cancer… twitter.com/i/web/status/1…
08 Feb 23 copy & paste +upvote -downvote 🙌 Data from this one-stop-shop comprehensive #CancerScreening center shows early detection of many different cancer… https://t.co/WhoCkeHX1t
3.
JCO_ASCO
#JCO #CommentsAndControversies: Suggested approaches to reduce cancer's employment pitfalls across diagnoses, job… twitter.com/i/web/status/1…
21 Nov 22 copy & paste +upvote -downvote 🤔 #JCO #CommentsAndControversies: Suggested approaches to reduce cancer's employment pitfalls across diagnoses, job… https://t.co/PGLUJFVupM
4.
JCO_ASCO
#JCO #BiologyOfNeoplasia: Germline ATM variants are uniquely abundant in 24% of #ChronicLymphcyticLeukemia patien… twitter.com/i/web/status/1…
14 Nov 22 copy & paste +upvote -downvote 🧐 #JCO #BiologyOfNeoplasia: Germline ATM variants are uniquely abundant in 24% of #ChronicLymphcyticLeukemia patien… https://t.co/qls8a66NgP
5.
JCO_ASCO
@ASCO Guideline just published: Treatment of Metastatic Colorectal Cancer

Read in #JCO twitter.com/i/web/status/1…
17 Oct 22 copy & paste +upvote -downvote ‼️ @ASCO Guideline just published: Treatment of Metastatic Colorectal Cancer Read in #JCO ➡️… https://t.co/3HiDAFxysZ
6.
28 Apr 22 copy & paste +upvote -downvote 👍 Myeloma XI data - #MinimalResidualDisease #MRD status at both 3 and 9 mos after #AutologousStemCellTransplant is… https://t.co/IiDmTWU7Da
7.
JCO_ASCO
#AI-powered spatial analysis of tumor-infiltrating lymphocytes as a potentially complementary biomarker for immun… twitter.com/i/web/status/1…
11 Apr 22 copy & paste +upvote -downvote 🆕 #AI-powered spatial analysis of tumor-infiltrating lymphocytes as a potentially complementary biomarker for immun… https://t.co/K9biXn1sRn
8.
JCO_ASCO
CD20 & CD3 bispecificAb, mosunetuzumab, well tolerated with durable complete response in relapsed/refractory indo… twitter.com/i/web/status/1…
05 Jan 22 copy & paste +upvote -downvote ✅ CD20 & CD3 bispecificAb, mosunetuzumab, well tolerated with durable complete response in relapsed/refractory indo… https://t.co/5pS9tmqf2o

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
http://www.iemoji.com/feed/JCO_ASCO
Back to top